HIF-1alpha is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis.

  • Luxembourg Center of Neuropathology
June 11, 2020 By:
  • Devraj G
  • Guerit S
  • Seele J
  • Spitzer D
  • Macas J
  • Khel MI
  • Heidemann R
  • Braczynski AK
  • Ballhorn W
  • Gunther S
  • Ogunshola OO
  • Mittelbronn M
  • Kodel U
  • Monoranu CM
  • Plate KH
  • Hammerschmidt S
  • Nau R
  • Devraj K
  • Kempf VAJ.

Bacterial meningitis is a deadly disease most commonly caused by Streptococcus pneumoniae, leading to severe neurological sequelae including cerebral edema, seizures, stroke, and mortality when untreated. Meningitis is initiated by the transfer of S. pneumoniae from blood to the brain across the blood-cerebrospinal fluid barrier or the blood-brain barrier (BBB). The underlying mechanisms are still poorly understood. Current treatment strategies include adjuvant dexamethasone for inflammation and cerebral edema, followed by antibiotics. The success of dexamethasone is however inconclusive, necessitating new therapies for controlling edema, the primary reason for neurological complications. Since we have previously shown a general activation of hypoxia inducible factor (HIF-1alpha) in bacterial infections, we hypothesized that HIF-1alpha, via induction of vascular endothelial growth factor (VEGF) is involved in transmigration of pathogens across the BBB. In human, murine meningitis brain samples, HIF-1alpha activation was observed by immunohistochemistry. S. pneumoniae infection in brain endothelial cells (EC) resulted in in vitro upregulation of HIF-1alpha/VEGF (Western blotting/qRT-PCR) associated with increased paracellular permeability (fluorometry, impedance measurements). This was supported by bacterial localization at cell-cell junctions in vitro and in vivo in brain ECs from mouse and humans (confocal, super-resolution, electron microscopy, live-cell imaging). Hematogenously infected mice showed increased permeability, S. pneumoniae deposition in the brain, along with upregulation of genes in the HIF-1alpha/VEGF pathway (RNA sequencing of brain microvessels). Inhibition of HIF-1alpha with echinomycin, siRNA in bEnd5 cells or using primary brain ECs from HIF-1alpha knock-out mice revealed reduced endothelial permeability and transmigration of S. pneumoniae. Therapeutic rescue using the HIF-1alpha inhibitor echinomycin resulted in increased survival and improvement of BBB function in S. pneumoniae-infected mice. We thus demonstrate paracellular migration of bacteria across BBB and a critical role for HIF-1alpha/VEGF therein and hence propose targeting this pathway to prevent BBB dysfunction and ensuing brain damage in infections.

2020 Jun. Acta Neuropathol. Online ahead of print.
Other information